Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Summer offer: 25% off the reader + 30% off your first reagent order
However, because the program may include fewer touchpoints or opportunities for follow-up, some users may prefer a model that offers closer clinical oversight
Body weight and waist circumference are obvious
Unlike MT-1 whose linear backbone and tridecapeptide length confer preferential MC1R activity, MT-IIs cyclic heptapeptide structure produces a more compact, conformationally rigid pharmacophore with enhanced affinity at the centrally expressed MC3R and MC4R subtypes alongside maintained MC1R activity and generating the distinctive multi-system pharmacological profile that encompasses skin pigmentation through MC1R, pro-sexual and pro-erectile effects through hypothalamic and limbic MC3R/MC4R activation, and anorexia and energy balance modulation through hypothalamic MC3R/MC4R
The naming follows the progression researchers and writers have used to describe the metabolic peptide field's evolution: GLP-1 (single receptor agonist like semaglutide), then dual agonist (GLP-1 + GIP, like tirzepatide), and now what some refer to as "GLP-3" (triple agonist activating GLP-1, GIP, and glucagon receptors, like retatrutide)
